Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Methylnaltrexone (MNTX) for the Relief of Constipation
This study has been completed.
Study NCT00402038   Information provided by Salix Pharmaceuticals

First Received on November 17, 2006.   Last Updated on July 18, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advance Illness Patients With OIC
Additional conditions recognized in this trial
Constipation
More general conditions related to this trial
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
SC Methylnaltrexone
SC Placebo
Additional drug interventions recognized in this trial
Methylnaltrexone
Naltrexone
More general drug interventions related to this trial
Central Nervous System Agents
Narcotic Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Salix Pharmaceuticals
Wyeth is now a wholly owned subsidiary of Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services